The largest database of trusted experimental protocols

Immuno beadchip array

Manufactured by Illumina

The Immuno-BeadChip array is a high-throughput laboratory equipment used for the simultaneous analysis of multiple biomarkers. It is designed to enable efficient and comprehensive immune profiling. The core function of the Immuno-BeadChip array is to facilitate the detection and quantification of a broad range of immune-related analytes in biological samples.

Automatically generated - may contain errors

2 protocols using immuno beadchip array

1

Genotyping Quality Control Procedures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genotyping was performed at Cedars-Sinai Medical Center using Illumina whole genome arrays (Human610-Quad; HumanOmniExpress) and the Immuno-BeadChip array as previously described16 (link), 18 (link). For the Immuno-BeadChip, average genotyping call rate for samples that passed quality control (QC) was 99.98%. Average concordance rate across 83 samples genotyped in replicate was 99.99%. Single-nucleotide polymorphisms (SNPs) underwent methodological review and were evaluated using several SNP statistic parameters, including SNP call frequency, cluster separation, replicate and heritability error rates, heterozygous excess, theta mean and deviation, and R intensity mean. A total of 135,252 autosomal SNPs passed genotyping QC measures and were common across datasets. For the Human OmniExpress and Human610-Quad, average genotyping call rates for samples that passed QC were 99.85% and 99.83%, respectively. Average concordance rate across 19 samples genotyped in replicate was >99.99%. Genotyping of three control trios yielded a heritability frequency of 99.53%. Optimal allele-calling was verified by manual review of top associated SNPs.
+ Open protocol
+ Expand
2

Stratification of CD Subjects by NOD2 and ATG16L1 Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genotyping was at Cedars-Sinai Medical Center using the Illumina Immuno-BeadChip array as previously described (2 (link), 19 (link)). All human subjects were homozygous non-risk for the 3 common CD-associated NOD2 variants (tagged by rs2066842-GG, rs2066844-GG, rs2066845-CC. rs5743293-DD) and then stratified by ATG16L1 CD-associated T300A variant status dividing the study subjects into those that were either homozygous non-risk or homozygous risk (as defined by rs2241880). Written informed consent was received from participants prior to inclusion in the study. All study subjects were identified by number and not by name, had not used antibiotics for at least 6 months. Stool, blood samples, and genetic data were obtained from Material and Information Resources for Inflammatory And Digestive Diseases (MIRIAD) IBD Biobank and approved under IRB #3358 and #Pro00027495.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!